Shortterm Efficacy of Topical Immunosuppressive Agents on the Survival of Cultivated AlloConjunctival Equivalents
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: To investigate the short-term efficacy of topical immunosuppressive agents on the survival of cultivated allo-conjunctival equivalents. Methods: Twenty-five eyes of New Zealand white rabbits were included. Temporal conjunctivae were trephined to a diameter of 7.5 mm, and then cultured allo-conjunctival epithelial cells on amniotic membrane were transplanted onto them. Various immunosuppressants including steroid, cyclosporine, and rapamycin were applied topically four times a day for a week. Epithelial defects and graft edema were graded daily. Numbers of inflammatory cells were measured in H&E. PKH26 and cytokeratin 4 and 7 were immunostained. Results: Earlier epithelialization was observed in 1% steroid-treated eyes and defects persisted significantly in 0.5% CsA applied eyes. In histology, PKH26 positive cells considered as donor cells were only found in 1% steroid or 0.01% rapamycin applied eyes. 1% steroid- or 0.01% rapamycin-applied eyes both showed positive staining for keratin-4 and -7. Inflammatory cells were less found in 1% steroid or 0.01% rapamycin treated eyes. Conclusions: Topical steroid or rapamycin can help to suppress acute inflammation and enhance the acute survival of transplanted conjunctival cells.
Abstract
Purpose: To investigate the short-term efficacy of topical immunosuppressive agents on the survival of cultivated allo-conjunctival equivalents. Methods: Twenty-five eyes of New Zealand white rabbits were included. Temporal conjunctivae were trephined to a diameter of 7.5 mm, and then cultured allo-conjunctival epithelial cells on amniotic membrane were transplanted onto them. Various immunosuppressants including steroid, cyclosporine, and rapamycin were applied topically four times a day for a week. Epithelial defects and graft edema were graded daily. Numbers of inflammatory cells were measured in H&E. PKH26 and cytokeratin 4 and 7 were immunostained. Results: Earlier epithelialization was observed in 1% steroid-treated eyes and defects persisted significantly in 0.5% CsA applied eyes. In histology, PKH26 positive cells considered as donor cells were only found in 1% steroid or 0.01% rapamycin applied eyes. 1% steroid- or 0.01% rapamycin-applied eyes both showed positive staining for keratin-4 and -7. Inflammatory cells were less found in 1% steroid or 0.01% rapamycin treated eyes. Conclusions: Topical steroid or rapamycin can help to suppress acute inflammation and enhance the acute survival of transplanted conjunctival cells.
참고문헌 (43)
- Thoft RA, "Conjunctival transplantation", Arch Ophthalmol, 95, pp.1425~7 (1977)
- Kwitko S, "Allograft conjunctival transplantation for bilateral ocular surface disorders", Ophthalmology, 102, pp.1020~5 (1995)
- Järplid B, "Rejection of skin and conjunctival allografts in the dog after prolonged graft survival", Acta Chir Scand, 139, pp.517~21 (1973)
- Obel N, "Transplantation of allogeneic conjunctiva as a complement to allogeneic skin grafting when studying immunosuppressive procedures in the dog", Acta Chir Scand, 138, pp.21~4 (1972)
- Nussenblatt RB, "Uveiti, 2nd", pp.106~22 (1996), St.Louis: Mosby
- Dios E, "Efficacy of systemic cyclosporine A and amniotic membrane on rabbit conjunctival limbal allograft rejection", Cornea, 24, pp.182~8 (2005)
- 권영삼, "Inhibition of corneal neovascularization by rapamycin", Experimental and Molecular Medicine, 38(2), pp.173~179 (2006), 대한생화학ㆍ분자생물학회
- Kwon YS, "effect of rapamycin on corneal neovascularization in vitro and in vivo", Invest Ophthalmol Vis Sci, 46, pp.454~60 (2005)
- Ebrahem Q, "Triamcinolone acetonide inhibits IL‐6‐ and VEGF‐induced angiogenesis downstream of the IL‐6 and VEGF receptors", Invest Ophthalmol Vis Sci, 47, pp.4935~41 (2006)
- Benelli U, "Corneal neovascularization induced by xenografts or chemical cautery", Inhibition by cyclosporin A. Invest Ophthalmol Vis Sci, 38, pp.274~82 (1997)
- De Saint Jean M, "Comparison of morphological and functional characteristics of primary‐cultured human conjunctival epithelium and of Wong‐Kilbourne derivative of Chang conjunctival cell line", Exp Eye Res, 78, pp.257~74 (2004)
- Bell TA, "Cyclosporin A: tissue levels following topical and systemic administration to rabbits", Br J Ophthalmol, 70, pp.852~5 (1986)
- Wiederholt M, "Hoffmann F. Pharmacokinetic of topical cyclosporin A in the rabbit eye", Invest Ophthalmol Vis Sci, 27, pp.519~24 (1986)
- Kaswan RL, "Intraocular penetration of topically applied cyclosporine", Transplant Pro, 20, pp.650~5 (1988)
- Stamer L, "Tissue levels of locally applied cyclosporin A in the rabbit eye", Fortschr Ophthalmol, 86, pp.540~2 (1989)
- Mosteller MW, "Penetration of topical cyclosporine into the rabbit cornea, aqueous humor, and serum", Arch Ophthalmol, 103, pp.101~2 (1985)
- Okada K, "Effect of FK 506 administered topically versus intramuscularly on suppression of the corneal immune reaction in rats", Ophthalmologica, 210, pp.175~9 (1996)
- Benelli U, "FK‐506 delays corneal graft rejection in a model of corneal xenotransplantation", J Ocul Pharmacol Ther, 12, pp.425~31 (1996)
- Hikita N, "Effects of topical FK506 on endotoxin‐induced uveitis (EIU) in the Lewis rat", Curr Eye Res, 14, pp.209~14 (1995)
- Hikita N, "Use of topical FK506 in a corneal graft rejection model in Lewis rats", Invest Ophthalmol Vis Sci, 38, pp.901~9 (1997)
- Ang LP, "Development of a conjunctival epithelial equivalent with improved proliferative properties using a multistep serum‐free culture system", Invest Ophthalmol Vis Sci, 45, pp.1789~95 (2004)
- Ang LP, "The in vitro and in vivo proliferative capacity of serum‐free cultivated human conjunctival epithelial c", Curr Eye Res, 28, pp.307~17 (2004)
- Meller D, "Conjunctival epithelial cell differentiation on amniotic membrane", Invest Ophthalmol Vis Sci, 40, pp.878~86 (1999)
- Ang LP, "The development of a serum‐free derived bioengineered conjunctival epithelial equivalent using an ultrathin poly (epsilon‐caprolactone) membrane substrate", Invest Ophthalmol Vis Sci, 47, pp.105~12 (2006)
- Ang LP, "Autologous cultivated conjunctival transplantation for recurrent viral papillomata", Am J Ophthalmol, 140, pp.136~8 (2005)
- Nishida K, "Functional bioengineered corneal epithelial sheet grafts from corneal stem cells expanded ex vivo on a temperature‐responsive cell culture surface", Transplantation, 77, pp.379~85 (2004)
- Adinolfi M, "Expression of HLA antigens, ß2‐microglobulin and enzymes by human amniotic epithelial cells", Nature, 295, pp.325~7 (1982)
- Akle CA, "Immunogenicity of human amniotic epithelial cells after transplantation into volunteers", Lancet, 2, pp.1003~5 (1981)
- Horan PK, "Stable cell membrane labelling", Nature, 340, pp.167~8 (1989)
- Horan PK, "Fluorescent cell labeling for in vivo and in vitro cell tracking", Methods Cell Biol, 33, pp.469~90 (1990)
- Slezak SE, "Fluorescent in vivo tracking of hematopoietic cells. Part I. Technical considerations", Blood, 74, pp.2172~7 (1989)
- Slezak SE, "Radioactive cell membrane labelling", Nature, 352, pp.261~2 (1991)
- Teare GF, "Long‐term tracking of lymphocytes in vivo: the migration of PKH‐labeled lymphocytes", Cell Immunol, 134, pp.157~70 (1991)
- Bertelmann E, "Immunomodulatory therapy in ophthalmology ‐ is there a place for topical application?", Ophthalmologica, 218, pp.359~67 (2004)
- Claman HN, "Corticosteroids as immunomodulators", Ann N Y Acad Sci, 685, pp.288~92 (1993)
- Nussenblatt RB, "Uveitis, 2nd", pp.99~106 (1996), St.Louis: Mosby
- Olsen TW, "Rapamycin inhibits corneal allograft rejection and neovascularization", Arch Ophthalmol, 112, pp.1471~5 (1994)
- Ohia EO, "Effects of steroids and immunosuppressive drugs on endotoxin‐uveitis in rabbits", J Ocul Pharmacol, 8, pp.295~307 (1992)
- Roberge FG, "Treatment of autoimmune uveoretinitis in the rat with rapamycin, an inhibitor of lymphocyte growth factor signal transduction", Curr Eye Res, 12, pp.197~203 (1993)
- Sehgal SN, "Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression", Clin Biochem, 39, pp.484~9 (2006)
- Sehgal SN, "Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression", Clin Biochem, 31, pp.335~40 (1998)
- Garweg JG, "Effects of daunorubicin, mitomycin C, azathiprine and cyclosporine A on human retinal pigmented epithelial, corneal endothelial and conjunctival cell lines", Graefes Arch Clin Exp Ophthalmol, 244, pp.382~9 (2006)
- Nelson JD, "The Conjunctiva: anatomy and physiology. In: Krachmer JH, Mannis MJ, Holland EJ, ed", Cornea. Philadelphia: Elsevier Mosby, 2 (2005)